SCHEMBL830158

SCHEMBL830158

C=COc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPB1 P04792 1/20 0.50
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA9 Q16790 1/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
PTGS2 P35354 1/20 0.46
ALDH1A1 P00352 3/20 0.45
HSD17B10 Q99714 2/20 0.45
ACHE P22303 2/20 0.45
MAPK1 P28482 2/20 0.44
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
TGM2 P21980 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
THRB P10828 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
APP P05067 1/20 0.44
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4818197 0.91 APP (0.55) PTGS2ALDH1A1HSD17B10MAPK1LMNA
SCHEMBL8433 0.81 HSPB1 (0.52) HSPB1CA1CA2CA9CES2
SCHEMBL28049499 0.79 HSPB1 (0.50) HSPB1CA1CA2CA9CES2
SCHEMBL28135398 0.79 HSPB1 (0.50) HSPB1CA1CA2CA9CES2
SCHEMBL28049513 0.79 HSPB1 (0.50) HSPB1CA1CA2CA9CES2
Ammonia Solution, Strong SCHEMBL27663814 0.79 HSPB1 (0.50) HSPB1CA1CA2CA9CES2
SCHEMBL5847950 0.79 HSPB1 (0.50) HSPB1CA1CA2CA9CES2
SCHEMBL13665383 0.79 HSPB1 (0.55) HSPB1CA1CA2CA9CES2
SCHEMBL535259 0.79 HSD17B10 (0.50) HSPB1CA1CA2CA9CES2
Hydrochloric Acid SCHEMBL27912110 0.79 HSPB1 (0.50) HSPB1CA1CA2CA9CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622687-B1 Toner for developing electrostatic images, one-component type developer, two-component type developer, and process for producing toner particles CANON KK (JP) 2000-10-25 EP claimed
US-5470687-A Process for producing toner particles using free space formed in a polymeric medium CANON KABUSHIKI KAISHA (JP) 1995-11-28 US claimed
EP-0622687-A2 Toner for developing electrostatic images, one-component type developer, two-component type developer, and process for producing toner particles CANON KABUSHIKI KAISHA (JP) 1994-11-02 EP claimed
US-20250092171-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME TOSOH FINECHEM CORPORATION (JP) 2025-03-20 US disclosed
CN-118843614-A High-purity 4- (2-bromoethyl) benzenesulfonic acid, high-purity styrenesulfonic acid derived therefrom, polymer thereof, and process for producing these 东曹精细化工株式会社 2024-10-25 CN disclosed
EP-3666753-B1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF TOSOH FINECHEM CORP (JP) 2024-09-11 EP disclosed
US-20240191087-A1 WATER DISPERSIBLE SULFONATED THERMOPLASTIC COPOLYMER FOR USE IN ADDITIVE MANUFACTURING STRATASYS INC (US) 2024-06-13 US disclosed
US-11939480-B2 Water dispersible sulfonated thermoplastic copolymer for use in additive manufacturing STRATASYS, INC. (US) 2024-03-26 US disclosed
WO-2023171597-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACIDS DERIVED THEREFROM AND POLYMERS THEREOF, AND METHODS FOR PRODUCING SAME 東ソー・ファインケム株式会社 2023-09-14 WO disclosed
US-11459410-B2 High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof TOSOH FINECHEM CORPORATION (JP) 2022-10-04 US disclosed
CN-110997631-B High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof 东曹精细化工株式会社 2022-07-15 CN disclosed
US-5728501-A POLYMERS OF ETHYLENICALLY UNSATURATED MONMERS SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1998-03-17 US disclosed
EP-0801335-A1 Magnetic coated carrier, two-component type developer and developing method CANON KABUSHIKI KAISHA (JP) 1997-10-15 EP disclosed
US-5652358-A Solid-phase synthesis of oligoribonucleotides HOECHST AKTIENGESELLSCHAFT (DE) 1997-07-29 US disclosed
US-5470687-A Process for producing toner particles using free space formed in a polymeric medium CANON KABUSHIKI KAISHA (JP) 1995-11-28 US disclosed
EP-0661291-A1 Solid phase synthesis of oligoribonucleotide HOECHST AKTIENGESELLSCHAFT (DE) 1995-07-05 EP disclosed
EP-0622687-A2 Toner for developing electrostatic images, one-component type developer, two-component type developer, and process for producing toner particles CANON KABUSHIKI KAISHA (JP) 1994-11-02 EP disclosed
US-4472434-A MEXICAN BEAN BEETLES SCHERING AKTIENGESELLSCHAFT (DE) 1984-09-18 US disclosed
US-4058443-A PHOTOPOLYMERIZATION, BINDER, CHLORINATED POLYOLEFIN FUJI PHOTO FILM CO., LTD. (JA) 1977-11-15 US disclosed
US-4050936-A Image forming process with photopolymer layers between a support and a substrate FUJI PHOTO FILM CO., LTD. (JA) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11459410-B2 High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof SLC7A1, ARSA, STS HSPB1 2849/4885CA1 3904/4885CA2 2972/4885
US-20250092171-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME BRPF1, WEE2, WEE1 HSPB1 3892/4885CA1 4151/4885CA2 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.